Evidence map›Paper›PMID 41539720›Full record

ArticleThe European respiratory journal2026

From symptoms to mechanisms: multidimensional insights into cannabis smoke.

Conglin Liu, Zhaozhong Zhu

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The European respiratory journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Conglin LiuSanofi, Cambridge, MA, USA.
Zhaozhong ZhuDepartment of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA zzhu5@mgh.harvard.edu.ORCID https://orcid.org/0000-0001-5662-1541

Funding

Residential Greenness, Airway Microbiome,and Incident Childhood AsthmaR01ES036966 · NIEHS · MASSACHUSETTS GENERAL HOSPITAL · PI ZHU, ZHAOZHONG · 2025 to 2025
$3.2M
Integrating the genome, metabolome, and microbiome for childhood asthma: Risk and endotypesK01AI153558 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ZHU, ZHAOZHONG · 2021 to 2025
$663k
NIAID NIH HHS K01 AI153558NIEHS NIH HHS R01 ES036966
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41539720
PMCPMC12832070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.